CIA
OMCL icon

CSat Investment Advisory’s Omnicell OMCL Stock Holding History

CSat Investment Advisory’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-216
Closed -$16K – 822
2020
Q3 		$16K Buy
216
+28
+15% +$1.94K ﹤0.01% 930
2020
Q2 		$13K Buy
+188
New +$12.9K ﹤0.01% 974

Other funds holding OMCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CSat Investment Advisory's OMCL Position: Q4 2020 in Review

CSat Investment Advisory sold out of Omnicell (OMCL) in Q4 2020, closing a stake of 216 shares — an estimated $16K sold.

CSat Investment Advisory first reported a position in OMCL in Q2 2020 and held it in 2 quarters. The position peaked at $16K in Q3 2020. 354 funds tracked by Wall St. Rank hold OMCL as of Q4 2020.

  • CSat Investment Advisory reported no remaining Omnicell position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 216 Omnicell shares in Q4 2020, an estimated $16K.
  • CSat Investment Advisory first reported a position in Omnicell in Q2 2020 and held it in 2 quarters.
  • CSat Investment Advisory's Omnicell position peaked at $16K in Q3 2020.
  • 354 funds tracked by Wall St. Rank held Omnicell as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.